Concepedia

Author

Marisa Winkler

Case Western Reserve UniversityORCID

Also Known As

Jessica N. Williams, M Winkler, Marisa L Winkler, Marisa L. Winkler, Marisa L. Winkler (510009), Marisa Winkler

71

Publications

2.7K

Citations

17

H-Index

27

Concepts

All Affiliations

Case Western Reserve UniversityLouis Stokes Cleveland VA Medical CenterBrigham and Women's HospitalCleveland State UniversityUniversity of Florida
MW

About

Marisa Winkler is an author at Case Western Reserve University specializing in microbiology, antimicrobial resistance, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

240

2

Microbiology

5

5

240

3

Health Sciences

3

3

190

4

Biochemistry

2

2

24

5

Natural Sciences

1

1

10

Marisa Winkler

×

18

Publications

1.1K

Citations

15

H-Index

YearCitations

Unexpected Challenges in Treating Multidrug-Resistant Gram-Negative Bacteria: Resistance to Ceftazidime-Avibactam in Archived Isolates of Pseudomonas aeruginosa

Marisa Winkler, Krisztina M. Papp‐Wallace, Andrea M. Hujer,

Antimicrobial Agents and Chemotherapy

2014

139

Activity of ceftazidime/avibactam against isogenic strains of <i>Escherichia coli</i> containing KPC and SHV β-lactamases with single amino acid substitutions in the Ω-loop

Marisa Winkler, Krisztina M. Papp‐Wallace, Robert A. Bonomo

Journal of Antimicrobial Chemotherapy

2015

133

<i>Klebsiella pneumoniae</i> Carbapenemase-2 (KPC-2), Substitutions at Ambler Position Asp179, and Resistance to Ceftazidime-Avibactam: Unique Antibiotic-Resistant Phenotypes Emerge from β-Lactamase Protein Engineering

Melissa D. Barnes, Marisa Winkler, Magdalena A. Taracila,

mBio

2017

121

Exploring the Role of a Conserved Class A Residue in the Ω-Loop of KPC-2 β-Lactamase

Peter Levitt, Krisztina M. Papp‐Wallace, Magdalena A. Taracila,

Journal of Biological Chemistry

2012

101

Variants of β-Lactamase KPC-2 That Are Resistant to Inhibition by Avibactam

Krisztina M. Papp‐Wallace, Marisa Winkler, Magdalena A. Taracila,

Antimicrobial Agents and Chemotherapy

2015

100

Avibactam and Inhibitor-Resistant SHV β-Lactamases

Marisa Winkler, Krisztina M. Papp‐Wallace, Magdalena A. Taracila,

Antimicrobial Agents and Chemotherapy

2015

76

Overcoming an Extremely Drug Resistant (XDR) Pathogen: Avibactam Restores Susceptibility to Ceftazidime for <i>Burkholderia cepacia</i> Complex Isolates from Cystic Fibrosis Patients

Krisztina M. Papp‐Wallace, Scott A. Becka, Elise T. Zeiser,

ACS Infectious Diseases

2017

75

Ceftazidime-Avibactam in Combination With Fosfomycin: A Novel Therapeutic Strategy Against Multidrug-Resistant Pseudomonas aeruginosa

Krisztina M. Papp‐Wallace, Elise T. Zeiser, Scott A. Becka,

The Journal of Infectious Diseases

2019

70

Boronic Acid Transition State Inhibitors Active against KPC and Other Class A β-Lactamases: Structure-Activity Relationships as a Guide to Inhibitor Design

Laura J. Rojas, Magdalena A. Taracila, Krisztina M. Papp‐Wallace,

Antimicrobial Agents and Chemotherapy

2016

51

Design and Exploration of Novel Boronic Acid Inhibitors Reveals Important Interactions with a Clavulanic Acid-Resistant Sulfhydryl-Variable (SHV) β-Lactamase

Marisa Winkler, Elizabeth A. Rodkey, Magdalena A. Taracila,

Journal of Medicinal Chemistry

2012

43

Page 1